The global antisense oligonucleotides market is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period. By 2033, it is estimated to amass revenue of approximately US$ 5,519.6 million, an impressive surge from US$ 2,913.5 million in 2023. Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5377 Unlocking …